NZ188211A - Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens - Google Patents

Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens

Info

Publication number
NZ188211A
NZ188211A NZ188211A NZ18821178A NZ188211A NZ 188211 A NZ188211 A NZ 188211A NZ 188211 A NZ188211 A NZ 188211A NZ 18821178 A NZ18821178 A NZ 18821178A NZ 188211 A NZ188211 A NZ 188211A
Authority
NZ
New Zealand
Prior art keywords
prp
haemophilus influenzae
influenzae type
strain
combined vaccine
Prior art date
Application number
NZ188211A
Other languages
English (en)
Inventor
J S-C Kuo
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/846,466 external-priority patent/US4196192A/en
Priority claimed from US05/846,488 external-priority patent/US4220717A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NZ188211A publication Critical patent/NZ188211A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/099Bordetella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ188211A 1977-10-28 1978-08-22 Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens NZ188211A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/846,466 US4196192A (en) 1977-10-28 1977-10-28 Combined Haemophilus influenzae type b and pertussis vaccine
US05/846,488 US4220717A (en) 1977-12-22 1977-12-22 Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.

Publications (1)

Publication Number Publication Date
NZ188211A true NZ188211A (en) 1984-09-28

Family

ID=27126641

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ188211A NZ188211A (en) 1977-10-28 1978-08-22 Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens

Country Status (25)

Country Link
JP (1) JPS5480408A (cg-RX-API-DMAC7.html)
AR (1) AR218932A1 (cg-RX-API-DMAC7.html)
AU (1) AU520902B2 (cg-RX-API-DMAC7.html)
BE (1) BE871586A (cg-RX-API-DMAC7.html)
CA (1) CA1117866A (cg-RX-API-DMAC7.html)
CH (1) CH649781A5 (cg-RX-API-DMAC7.html)
DD (1) DD140701A5 (cg-RX-API-DMAC7.html)
DE (1) DE2845745A1 (cg-RX-API-DMAC7.html)
DK (1) DK154327C (cg-RX-API-DMAC7.html)
ES (1) ES474611A1 (cg-RX-API-DMAC7.html)
FI (1) FI63674C (cg-RX-API-DMAC7.html)
FR (1) FR2407000B1 (cg-RX-API-DMAC7.html)
GB (1) GB2007244B (cg-RX-API-DMAC7.html)
GR (1) GR73991B (cg-RX-API-DMAC7.html)
HU (1) HU178166B (cg-RX-API-DMAC7.html)
IE (1) IE47474B1 (cg-RX-API-DMAC7.html)
IL (1) IL55433A (cg-RX-API-DMAC7.html)
IT (1) IT1107570B (cg-RX-API-DMAC7.html)
NL (1) NL7810753A (cg-RX-API-DMAC7.html)
NO (1) NO149611C (cg-RX-API-DMAC7.html)
NZ (1) NZ188211A (cg-RX-API-DMAC7.html)
PH (1) PH15882A (cg-RX-API-DMAC7.html)
PL (1) PL210545A1 (cg-RX-API-DMAC7.html)
SE (1) SE430753B (cg-RX-API-DMAC7.html)
YU (1) YU250878A (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
US4744982A (en) * 1982-08-24 1988-05-17 Hunter Kenneth W Human monoclonal antibody reactive with polyribosylribitol phosphate
ATE128628T1 (de) * 1990-08-13 1995-10-15 American Cyanamid Co Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
HU9400426D0 (en) * 1991-08-16 1994-05-30 Merck & Co Inc Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide
ATE176157T1 (de) * 1992-10-27 1999-02-15 American Cyanamid Co Pädiatrische kombinationsvakzine mit verbesserter immunogenizität jeder vakzine komponente

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
NO116869B (cg-RX-API-DMAC7.html) * 1965-01-19 1969-06-02 Merck & Co Inc
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
NL174267B (nl) * 1969-05-20 Roussel Uclaf Verbetering van de werkwijze voor de bereiding van een somatisch antigeen volgens het nederlandse octrooischrift 169754 en werkwijze ter bereiding van een farmaceutisch preparaat.
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
FR2253499B1 (cg-RX-API-DMAC7.html) * 1973-12-10 1977-11-04 Fabre Sa Pierre
DE2461439C3 (de) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides

Also Published As

Publication number Publication date
FR2407000B1 (cg-RX-API-DMAC7.html) 1983-01-21
IL55433A (en) 1982-09-30
IE47474B1 (en) 1984-03-21
IE782146L (en) 1979-04-28
GB2007244B (en) 1982-03-31
FR2407000A1 (cg-RX-API-DMAC7.html) 1979-05-25
JPS5480408A (en) 1979-06-27
AU520902B2 (en) 1982-03-04
NO149611C (no) 1984-05-23
IL55433A0 (en) 1978-10-31
CH649781A5 (de) 1985-06-14
DK154327C (da) 1989-04-03
DE2845745A1 (de) 1979-05-10
GR73991B (cg-RX-API-DMAC7.html) 1984-06-06
IT1107570B (it) 1985-11-25
GB2007244A (en) 1979-05-16
PL210545A1 (cg-RX-API-DMAC7.html) 1980-02-25
SE7811192L (sv) 1979-04-29
SE430753B (sv) 1983-12-12
HU178166B (en) 1982-03-28
DE2845745C2 (cg-RX-API-DMAC7.html) 1987-10-01
AR218932A1 (es) 1980-07-15
NO783635L (no) 1979-05-02
DD140701A5 (de) 1980-03-26
YU250878A (en) 1983-12-31
FI783269A7 (fi) 1979-04-29
NO149611B (no) 1984-02-13
BE871586A (fr) 1979-04-27
CA1117866A (en) 1982-02-09
ES474611A1 (es) 1980-01-16
JPS6231694B2 (cg-RX-API-DMAC7.html) 1987-07-09
DK479578A (da) 1979-04-29
AU4108178A (en) 1980-05-01
PH15882A (en) 1983-04-13
NL7810753A (nl) 1979-05-02
FI63674B (fi) 1983-04-29
FI63674C (fi) 1983-08-10
DK154327B (da) 1988-11-07
IT7851621A0 (it) 1978-10-24

Similar Documents

Publication Publication Date Title
US4220717A (en) Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
US4196192A (en) Combined Haemophilus influenzae type b and pertussis vaccine
RU2194531C2 (ru) Поливалентные ассоциированные коклюшно-дифтерийно-столбнячно (акдс)-полиомиелитные вакцины
US4459286A (en) Coupled H. influenzae type B vaccine
US4271147A (en) Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
DK155915B (da) Fremgangsmaade til fremstilling af pertussis-toksoid til anvendelse i vacciner
JPS61186328A (ja) 新規錯体
JPH0662436B2 (ja) 静注用免疫グロブリン製剤の製造方法
JP3789135B2 (ja) 凝集原製剤およびその製剤方法
Anderson et al. Isolation of the capsular polysaccharide from culture supernatant of Haemophilus influenzae type b
EP0407037B1 (en) Process for removing bacterial endotoxin from gram-negative polysaccharides
EP0527753A1 (en) CLEANING A PERTUSSIS EXTERIOR MEMBRANE PROTEIN.
JPS638340A (ja) レトロウイルスを含まぬ免疫グロブリンの製法
NZ188211A (en) Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
JPS62258326A (ja) ボルデテラ属細菌の蛋白質抗原の精製方法
CA1137901A (en) Isolation of capsular polysaccharide of haemophilus influenzae
KR810001317B1 (ko) 혼합백신의 제조방법
US3208909A (en) Anaerobic process for production of a gel-adsorbed anthrax immunizing antigen
US5039610A (en) Process for removing bacterial endotoxin from gram-negative polysaccharides
JP4777599B2 (ja) ヒト抗胸腺細胞免疫グロブリンの製造方法
JP4003235B2 (ja) 静注用免疫グロブリン製剤の製造方法
JP3747077B2 (ja) 百日咳菌由来感染防御成分の分離取得方法
JPS5872526A (ja) モノクロ−ルhbs抗体の製造方法
GB1570958A (en) Immunogenic product of tetanus toxin
Rao IN VIVO TRANSFER OF IMMUNITY BY THE IMMUNOGENIC RNA AND DETERMINATION OF MACROPHAGE ROLE IN THE PRODUCTION OF IMMUNOGENIC RNA.